BRAINSTORM CELL THERAPEUTICS INC. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001104659-26-062648
- Form type
- 10-Q
- CIK
- 0001137883
- Primary document
- https://www.sec.gov/Archives/edgar/data/1137883/000110465926062648/bcli-20260331x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BRAINSTORM CELL THERAPEUTICS INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-2.0M | - | - |
| Net Income | $-2.1M | - | - |
| Eps Basic | -0.19 | - | - |
| Eps Diluted | -0.19 | - | - |
| Cash And Equivalents | $15,000 | - | - |
| Total Assets | $755,000 | - | - |
| Total Liabilities | $11.8M | - | - |
| Shareholders Equity | $-11.0M | - | - |
| Operating Cash Flow | $-1.3M | - | - |